MedTrace Logo

Exogenous Sex Hormones and PONV

NCT06816355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7348

Last updated 2025-02-21

No results posted yet for this study

Summary

This study aims to investigate the rates of postoperative nausea and vomiting in transgender patients on hormone therapy compared to cisgender patients undergoing the same procedures (hysterectomy, orchiectomy, augmentation mammoplasty).

Conditions

  • Postoperative Nausea and Vomiting
  • Sex Hormone
  • Transgender

Interventions

PROCEDURE

Orchiectomy

CPT:54520

PROCEDURE

Hysterectomy

CPT:1013911

PROCEDURE

Augmentation mammoplasty

CPT:19325

Sponsors & Collaborators

  • Riverside University Health System Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-04
Primary Completion
2025-02-04
Completion
2025-02-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06816355 on ClinicalTrials.gov